Literature DB >> 11523223

Total cavopulmonary connection for complex cardiac anomalies with the functional single ventricle.

X Jinag1, Z Sun, K Zhang, P Fu.   

Abstract

From Aug. 1999 to Feb. 2001, 8 patients with complex congenital heart diseases, including 5 cases accompanied by hypoplastic left ventricle and 3 by hypoplastic right ventricle, were subjected to total cavopulmonary connection (TCPC). Eight cases underwent the operation under cardiopulmonary bypass and 7 of whom under no cardiac clamp. Seven cases received cavopulmonary anastomosis by flaring method and one case by end-side anastomosis. All the patients underwent the intracardiac tunnels to drain inferior vena cava and plus 4 mm fenestration except one. The results showed that 6 patients had postoperative oxygen saturation more than 90%, sinus rhythm, no anastomostic stoma obstruction, no flow regurgitation and CVP < 16 cmH2O. Two (25%) patients died postoperatively from high venous pressure of 18-20 cmH2O, finally from cardiac failure and anoxima. It was concluded that TCPC was an effective treatment for complex congenital cardiac diseases, especially with ventricular maldevelopment. Intracardiac tunnel plus 4 mm fenestration and flaring cavopulmonary anastomosis could prevent the postoperative complications. Larger anastomotic stoma, venous pressure less than 16 cmH2O and artery saturation more than 90% might indicate excellent TCPC procedures in our experience.

Entities:  

Mesh:

Year:  2001        PMID: 11523223     DOI: 10.1007/BF02888082

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  9 in total

1.  Computational fluid dynamic simulations of cavopulmonary connections with an extracardiac lateral conduit.

Authors:  F Migliavacca; M R de Leval; G Dubini; R Pietrabissa; R Fumero
Journal:  Med Eng Phys       Date:  1999-04       Impact factor: 2.242

2.  Pulmonary blood flow distribution after the total cavopulmonary connection for complex cardiac anomalies.

Authors:  M Tayama; N Hirata; T Matsushita; T Sano; N Fukushima; Y Sawa; T Nishimura; H Matsuda
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

3.  Toward designing the optimal total cavopulmonary connection: an in vitro study.

Authors:  A E Ensley; P Lynch; G P Chatzimavroudis; C Lucas; S Sharma; A P Yoganathan
Journal:  Ann Thorac Surg       Date:  1999-10       Impact factor: 4.330

4.  [The value of magnetic resonance tomography (MRT) for evaluating ventricular and anastomotic functions in patients with an extra- or intracardiac total cavopulmonary connection (TCPC)-modified Fontan operation].

Authors:  M Gutberlet; N Hosten; H Abdul-Khaliq; S Rechter; P Vojtovic; H Oellinger; T Ehrenstein; M Vogel; V Alexi-Meshkishvili; R Hetzer; R Felix
Journal:  Rofo       Date:  1999-12

5.  In vivo evaluation of Fontan pathway flow dynamics by multidimensional phase-velocity magnetic resonance imaging.

Authors:  E Be'eri; S E Maier; M J Landzberg; T Chung; T Geva
Journal:  Circulation       Date:  1998 Dec 22-29       Impact factor: 29.690

6.  What factors affect ventricular performance after a Fontan-type operation?

Authors:  H Uemura; T Yagihara; Y Kawashima; F Yamamoto; K Nishigaki; O Matsuki; K Okada; T Kamiya; R H Anderson
Journal:  J Thorac Cardiovasc Surg       Date:  1995-08       Impact factor: 5.209

7.  Comparison of cardiopulmonary adaptation during exercise in children after the atriopulmonary and total cavopulmonary connection Fontan procedures.

Authors:  M Rosenthal; A Bush; J Deanfield; A Redington
Journal:  Circulation       Date:  1995-01-15       Impact factor: 29.690

8.  Hyperventilation impairs oxygenation after bidirectional superior cavopulmonary connection.

Authors:  S M Bradley; J M Simsic; D M Mulvihill
Journal:  Circulation       Date:  1998-11-10       Impact factor: 29.690

9.  Establishment of total cavopulmonary connection without use of cardiopulmonary bypass.

Authors:  H Uemura; T Yagihara; K Yamashita; T Ishizaka; K Yoshizumi; Y Kawahira
Journal:  Eur J Cardiothorac Surg       Date:  1998-05       Impact factor: 4.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.